Sonoma Pharmaceuticals appoints Vanessa Jacoby to board; Birnbaum retires as director

Sonoma Pharmaceuticals, Inc.

Dr. Jay Birnbaum retired from board Jan 28, 2026; will serve as consultant for one year, receiving 5,000 RSUs per quarter.
Vanessa Jacoby appointed director effective Jan 28, replaces Birnbaum as independent director; will chair Audit Committee.
Jacoby receives initial grant of options to purchase 10,000 shares vesting over 3 years; annual retainer $32,500 plus committee fees.
Board amended director compensation plan to allow discretion in annual option grant size and form of initial equity grants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.